Lipocine's licensing partner, Verity Pharmaceuticals, announced Health Canada's approval of TLANDO, an oral testosterone replacement therapy for adult males with hypogonadism. TLANDO offers a convenient fixed-dose oral alternative to injections and gels, which often require titration and have compliance issues. Verity Pharma plans to launch TLANDO in Canada by the end of 2026, targeting a large market with over 700,000 annual TRT prescriptions. This approval expands TLANDO's reach in North America and supports Lipocine's commercial strategy.
Lipocine's TLANDO approval news is presented here with Health-sector market data for context. For readers following the Health sector, 44 of 100 priced US stocks rose while 50 fell today. Notable movers include HRTX at USD 0.34 (+2.50%), NUWE at USD 0.68 (-2.41%), and MESO at USD 13.93 (+2.35%). This data is as of Oct 07, 2026 19:12 WIB.
Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...
Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...
Barclays has lowered its price target for Netflix shares from $80 to $70 due to concerns over slower revenue growth and rising content costs, especially for live programming. Despite Netflix's large subscriber base of 325 million, the company faces p...
Barclays has increased its price target for MetLife stock to $111 from $97, indicating potential upside as shares currently trade near $97.16. MetLife also declared a fourth-quarter 2026 dividend of $0.59 per common share, payable on December 8, 2026...
Nasdaq is enhancing its Calypso platform with agentic AI to improve trading and risk management, addressing manual post-trade tasks in financial services. Its Financial Technology unit saw 16% revenue growth and added numerous new clients, driven by ...
